<\/p>\n
NEW YORK<\/span><\/span>, Aug. 22, 2022<\/span><\/span> \/PRNewswire\/ — The “Sciatica Treatment Market by Type and Geography – Forecast and Analysis 2022-2026” report has been added to Technavio’s offering. The potential growth difference for the sciatica treatment market size between 2021 and 2026 is USD 2.52 bn<\/span>. To get the exact CAGR and the Y-O-Y growth rate, Request a FREE PDF Sample Report<\/p>\n \nKey Market Dynamics\n<\/p>\n <\/p>\n Latest market research report titled Sciatica Treatment Market by Type and Geography – Forecast and Analysis 2022-2026 has been announced by Technavio which is proudly partnering with Fortune 500 companies for over 16 years<\/p>\n Technavio offers key drivers, trends, and challenges that will impact the future of the sciatica treatment market. Buy Now\u00a0to gain access to this information<\/p>\n \nMarket Segmentation\n<\/p>\n By type, the non-surgical impact segment will have the highest market share growth during the forecast period. Non-surgical treatments for sciatica include epidural non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroid injections, narcotics, muscle relaxants, tricyclic antidepressants, anti-seizure medications, and physical therapies. The availability of off-label epidural corticosteroid injections is driving the growth of this segment. Corticosteroids are the primary option for inflammation caused by sciatica.<\/p>\n North America<\/span>\u00a0will be the leading region with 37% of the market’s growth during the forecast period. The US and Canada<\/span> are the key countries for the sciatica treatment market in\u00a0the region. The growth of this region is attributed to factors such as rising awareness about the condition and strategic alliances among vendors. However, market growth in this region will be slower than the growth of the market in other regions.<\/p>\n View our FREE PDF sample report\u00a0for insights into the contribution of all the segments and regional opportunities in the sciatica treatment market report.<\/p>\n \nSome Companies Mentioned\n<\/p>\n Want your report customized? Speak to an analyst\u00a0and personalize your report according to your needs.<\/p>\n \nRelated Reports\n<\/p>\n Celiac Diseases Drugs Market\u00a0by Therapy Type and Geography – Forecast and Analysis 2022-2026<\/p>\n Polycystic Kidney Disease Drugs Market\u00a0by Type and Geography – Forecast and Analysis 2022-2026<\/p>\n Sciatica Treatment Market Scope<\/span><\/p>\n<\/td>\n<\/tr>\n Report Coverage<\/span><\/p>\n<\/td>\n Details<\/span><\/p>\n<\/td>\n<\/tr>\n Page number<\/span><\/p>\n<\/td>\n 120<\/span><\/p>\n<\/td>\n<\/tr>\n Base year<\/span><\/p>\n<\/td>\n 2021<\/span><\/p>\n<\/td>\n<\/tr>\n Forecast period<\/span><\/p>\n<\/td>\n 2022-2026<\/span><\/p>\n<\/td>\n<\/tr>\n Growth momentum & CAGR<\/span><\/p>\n<\/td>\n Decelerate at a CAGR of 4.3%<\/span><\/p>\n<\/td>\n<\/tr>\n Market growth 2022-2026<\/span><\/p>\n<\/td>\n USD 2.52 billion<\/span><\/p>\n<\/td>\n<\/tr>\n Market structure<\/span><\/p>\n<\/td>\n Fragmented<\/span><\/p>\n<\/td>\n<\/tr>\n YoY growth (%)<\/span><\/p>\n<\/td>\n 4.69<\/span><\/p>\n<\/td>\n<\/tr>\n Regional analysis<\/span><\/p>\n<\/td>\n North America, Europe, Asia, and Rest of World (ROW)<\/span><\/p>\n<\/td>\n<\/tr>\n Performing market contribution<\/span><\/p>\n<\/td>\n North America at 37%<\/span><\/p>\n<\/td>\n<\/tr>\n Key consumer countries<\/span><\/p>\n<\/td>\n US, Canada, Australia, UK, Germany, and China<\/span><\/p>\n<\/td>\n<\/tr>\n Competitive landscape<\/span><\/p>\n<\/td>\n Leading companies, competitive strategies, consumer engagement scope<\/span><\/p>\n<\/td>\n<\/tr>\n Companies profiled<\/span><\/p>\n<\/td>\n Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Bayer AG, Dr. Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Johnson and Johnson, Lupin Ltd., Nidd Valley Medical, Novartis AG, Omega Laser Systems Ltd., Ozone Pharmaceuticals Ltd., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.<\/span><\/p>\n<\/td>\n<\/tr>\n Market Dynamics<\/span><\/p>\n<\/td>\n Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.<\/span><\/p>\n<\/td>\n<\/tr>\n Customization purview<\/span><\/p>\n<\/td>\n If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.<\/span><\/p>\n<\/td>\n<\/tr>\n<\/table>\n Browse Health Care\u00a0Market Reports<\/p>\n \nKey Topics Covered\n<\/p>\n 1 Executive Summary<\/p>\n 2 Market Landscape<\/p>\n 3 Market Sizing<\/p>\n 4 Five Forces Analysis<\/p>\n 5 Market Segmentation by Type<\/p>\n 6 Customer Landscape<\/p>\n 7 Geographic Landscape<\/p>\n\n
\n
\n
\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n